In a mouse skin explant model, TGF-β1 is produced by progressor types but not regressor squamous cell carcinoma lines, and this tumor-derived cytokine inhibits migration of professional APCs, Langerhans cells (LCs), and keeps them in an immature form [89], or transgenic expression of TGF-β1 enhances growth of regressor squamous carcinoma cells in vitro and in vivo just like progressor phenotype, and reduces the number of infiltrating LCs, CD4+ and CD8+ T cells [90]. This evidence concerns the gene TGFB1 and squamous cell carcinoma.